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ABSTRACT
Introduction: Chronic pain (CP) negatively
impacts the lives of almost 2 billion people
worldwide, including approximately 37% of
adults in Portugal. As most of these patients are
followed by a general practitioner, identifying
the prevalence and characterizing the pain of
patients who visit primary care units will pro-
vide valuable insights into the CP landscape in
Portugal.
Methods: To achieve this goal, an observa-
tional, cross-sectional study was conducted in
58 primary care units of mainland Portugal
between June 2017 and March 2018. Interviews
were conducted with 8445 patients, and 578 CP
patients were characterized.
Results: We observed that one third of patients
suffered from CP, and of these, approximately
one third felt that their pain management was
insufficient. Most of the population was
55 years old or older, retired, and had more
than three comorbidities. However, age and the
number and type of comorbidities were not
predictors of pain intensity. Additionally, most
of the population had pain or discomfort that
hindered their mobility and the performance of
their everyday activities. This decrease in the
quality of life led to feelings of anxiety and
depression, which were associated with pain
intensity.
Conclusion: Given the high prevalence of CP,
strategies to improve the quality of life of these
patients and decrease the negative impacts, as
well as awareness campaigns to increase the
populations’ knowledge of this condition, are
essential for the suitable and timely treatment
of CP.
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Why carry out this study?
In Portugal, there is a paucity of
information regarding the
characterization of patients with chronic
pain who visit primary care units, and no
real-world data are available regarding
chronic pain epidemiology in this setting.
This study bridges the existent gap by
providing valuable information on the
prevalence of chronic pain and its impact
on the quality of life of patients who visit
primary care units.
What was learned from the study?
Chronic pain affects one third of patients
who present to primary care units and has
a significant impact on the quality of life
of patients in all domains, mainly on
psychological status, with feelings of
anxiety and/or depression.
Roughly one in three chronic pain
patients did not consider that their pain
was correctly managed. This observation
highlights the need to raise awareness
about this multidimensional condition.
INTRODUCTION
Chronic pain (CP) affects approximately 1.9
billion people worldwide [1], including
approximately 37% of the Portuguese popula-
tion [2]. It has been defined as ‘‘an unpleasant
sensory and emotional experience associated
with, or resembling that associated with, actual
or potential tissue damage’’ which has persisted
after the cause has been healed or for longer
than 3 months [3, 4]. Usually considered an
outcome of injury or disease, CP has been clas-
sified as a distinct clinical entity and not as a
consequence of other diseases [1, 5]. This con-
dition impacts many aspects of patients’ lives,
affecting home/family responsibilities, work,
social life and recreational activities [2, 6].
Accordingly, low back and neck pain, which are
symptomatic chronic conditions, are among
the main causes of disability [1]. Thus, besides
pain relief, treatment of chronic pain also
strives to minimize disability, decreasing phys-
ical and social limitations, and ultimately
improving the quality of life of the patients [7].
In most countries, patients first present to
primary care, as it provides accessible, continu-
ous, complete and coordinated care [4]. There-
fore, the majority of chronic pain patients are
followed by their general practitioner in pri-
mary care units (PCU) [4]. In 2006, a survey in
15 European countries (which did not include
Portugal and Israel) showed that only 2% of
patients with CP were referred to specialized
care [8, 9]. Moreover, approximately 50% of
patients received inadequate pain management
[8]. However, in Portugal, there is a paucity of
information regarding the characterization of
patients with CP who visit PCU.
This work reports the results of a cross-sec-
tional observational study based on interviews
of individuals aged 18 years or older who visited
58 Portuguese PCU within a period of
10 months. Patients with CP were selected, and
the prevalence and characteristics of CP diag-
nosis and management were assessed. The data
obtained from this study will help to improve
the timely diagnosis, referral, and proper man-
agement of CP by general practitioners, the first
point of contact for CP patients.
METHODS
Geographical Representation
and Compliance with Ethical Standards
This was an observational, cross-sectional study,
conducted at 58 PCU in mainland Portugal. The
study sites were chosen using a population
proportional sampling method and are thus
representative of the Portuguese population.
Patient interviews were conducted between
June 2017 and March 2018. Written informed
consent was obtained from all participants and
the study protocol was approved by local Ethics
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Committees. This work was conducted accord-
ing to the tenets of the Declaration of Helsinki
in its latest amendment (Brazil, 2013). The
leading ethical committee, representative of the
largest number of centers, Comissão de Ética
para a Saúde da Administração Regional de
Saúde do Norte, approved the study protocol
and the written informed consent form, with
approval reference number 99/2017. The names
of all ethics committees and the reference
numbers of the approvals are provided in
table S1 (Supplementary Material).
Eligibility Criteria
Eligibility criteria were as follows: (1) age
18 years or older and (2) being able and willing
to provide written informed consent. A total of
8480 interviews were conducted, but 35 were
excluded due to protocol deviations. Of the
8445 participants, 2834 suffered from CP. CP
patients were defined as individuals who (1) had
pain for more than 3 months, (2) had pain for
less than 3 months, but the pain persisted after
the cause was healed, or (3) had a previous
diagnosis of CP but were asymptomatic due to
suitable treatment. Of the 2834 CP patients, 578
were selected for further characterization.
Information Collected
Data on demographic characteristics, health-
care and pain characteristics, comorbidities, and
pharmacological and non-pharmacological
pain treatments were collected by the physician
during the patients’ regular medical appoint-
ments. The information was introduced in an
electronic case report form specifically designed
for this study, which included a section for the
patient information and another for the physi-
cian assessment. All information subject to
recall bias was collected from the medical
records. Pain intensity and the patients’ per-
ception regarding the understanding of pain
severity by the physician were assessed using
11-point Likert scales, with 0 corresponding to
no pain/understanding and 10 corresponding
to maximum pain/understanding. Pain relief
was assessed using a five-point Likert scale
comprising the categories ‘‘significant relief,’’
‘‘sufficient relief,’’ ‘‘some relief,’’ ‘‘small relief,’’
and ‘‘no relief.’’ Health-related quality of life was
evaluated using the EQ-5D-3L questionnaire
[10].
Statistical Analysis
An intent-to-treat (ITT) statistical analysis was
performed. According to the original statistical
analysis plan (SAP), statistical analysis was per-
formed with available data, and no method of
imputation for missing data was used. Quanti-
tative variables were tested for normality using
the Shapiro–Wilk test. Since the majority of
quantitative variables were not normally dis-
tributed, baseline median, interquartile range
(IQR), minimum and maximum are presented.
For categorical variables, number and percent-
age of total are presented. Between-group anal-
yses of quantitative variables were performed
using the Mann–Whitney or Kruskal–Wallis test
as appropriate, and adjusted for multiple com-
parisons using the Šidák correction when nee-
ded. For categorical variables, the v2 test was
used. Two univariate regressions were per-
formed to analyze if age was a predictor of the
maximum and average pain intensity. The
dependent variables were maximum and aver-
age pain intensity, and the independent vari-
able was age, being all these variables analyzed
as continuous. A significance level of a = 0.05
(two-sided) was used. The software used was the
SPSS version 23.0 statistical package.
RESULTS
Pain Prevalence and Characteristics
We observed that 33.6% of primary care unit
patients suffered from CP. The characterized
patients were all 25 years or older, and 73%
were 55 years or older. The cohort comprised
423 women (73.2%) and 155 men (26.8%). The
majority of patients were retired (48.8%), 22.8%
were still actively working, 14.4% were on sick
leave, 8% were housewives, 5.7% were unem-
ployed, and 0.3% were students. Most of the
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patients (60.9%) had more than three comor-
bidities, with those related to cardiometabolic
disorders being the most prevalent (74.6%)
(Table 1).
The median and IQR of the maximum pain
intensity reported during the previous week was
7.0 (3.0) on a scale of 1–10. The median and IQR
of average pain intensity reported during the
previous week was 5.0 (3.0), also on a scale of
1–10. More than 95% (n = 575) of patients were
under pharmacological treatment, and 69%
reported feeling some relief, while 31% felt
minor or no relief. Most of the patients were
diagnosed by a general practitioner (61.4%),
and approximately half (51.7%) were diagnosed
after experiencing symptoms for less than
1 year. CP had a negative impact on the
mobility and usual activities of patients, as most
of them reported having at least some problems
(66.4% and 66.8%, respectively) in performing
these activities. Additionally, 12.1% of patients
reported not being able to carry out their per-
sonal hygiene routine and/or get dressed by
themselves, and 41.3% reported having some
problems performing these activities. Accord-
ingly, 91.5% of patients reported feeling pain/
discomfort. Regarding anxiety/depression,
14.4% of patients were extremely depressed/
anxious, 54.2% were moderately depressed/
anxious, and 31.5% did not feel depressed/
anxious (Table 2).
Factors Influencing Pain Resolution
Expectations
CP patients and their physicians reported the
time that they expected would be needed to
achieve pain resolution. Physicians anticipated
successful resolution in less than 1 year for
patients with a lower number of visits to the
PCU and for patients who perceived that their
physician understood the severity of their pain.
Moreover, a higher number of medical tests
(performed in the previous 12 months) nega-
tively influenced physicians’ expectations of the
time needed for pain resolution.
Age did not have an impact on patients’
expectations regarding time for pain resolution.
Moreover, on regression analysis, age was not a
predictor of maximum or average pain intensity
reported by patients. The number of radiologi-
cal exams, on the other hand, influenced the
time expectation of patients. A higher number
Table 1 Sociodemographic characteristics of chronic pain
patients


























B 3 226 (39.1)
[ 3 352 (60.9)
Data presented in absolute values (percentage)
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of radiological exams was found for the group of
patients who predicted that[1 year would be
needed to achieve pain resolution, suggesting
that patients who undergo a greater number of
radiological exams expect that more time will
be needed to achieve pain resolution (Table 3).
Influence of Medical Specialty
on Diagnosis and Pain Management
Patients diagnosed and monitored by medical
specialties other than general practitioners
reported a higher level of maximum pain
intensity (8.0 vs. 7.0, p = 0.006; 7.5 vs. 7.0,
p = 0.008, respectively) (Fig. 1), but no signifi-
cant difference was found in the time needed to
diagnose CP. Median (IQR) values, in years,
from the time of first symptoms to diagnosis
were 0.5 (2.2) and 0.3 (2.0) for patients diag-
nosed by a general practitioner or by a physi-
cian from another medical specialty,
respectively.
Anxiety and Depression in CP Patients
Patients with higher levels of maximum pain
intensity were more likely to report feeling
moderately or extremely anxious and/or
depressed. Significant differences were found
between the groups that reported moderate and
extreme states of anxiety/depression when
compared with those who reported not feeling
anxious/depressed (p\0.001). No significant
differences were observed between patients who
Table 2 Characterization of the pain in CP patients
Pain characteristics No. (%)
(N = 578)
Pain relief
Some relief 399 (69.0)
Minor/no relief 179 (31.0)
Medical specialty that made the diagnosis
General practitioner 355 (61.4)
Rheumatologist 18 (3.1)
Pain specialist 10 (1.7)
Other 72 (12.5)
Unknown/not reported 123 (21.3)
Time between symptoms and diagnosis
\ 1 year 227 (39.3)
[ 1 year 212 (36.7)
Unknown/not reported 139 (24.0)
Mobility
No problems 189 (32.7)
I have some problems 384 (66.4)
Bedridden 5 (0.9)
Personal care
No problems 327 (56.6)
I have some problems with personal
hygiene/getting dressed
239 (41.3)




No problems 148 (25.6)
I have some problems 386 (66.8)













Data presented in absolute values (percentages)
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reported moderate or extreme levels of anxiety/
depression (see Fig. 2).
DISCUSSION
The main goal of this study was to assess and
characterize CP in patients who visit Portuguese
PCU. The prevalence of CP in this population
was 33.6%, which is in line with an epidemio-
logical study from 2012 that estimated CP
prevalence in Portugal of 36.7% [2]. Although
the study designs were different, since our study
focused on individuals who visit the PCU
whereas the study by Azevedo et al. was based
on computer-assisted telephone interviews to
the general population [2], both studies point to
approximately one third of the Portuguese
population being affected by CP.
Patients 55 years or older comprised 73% of
the studied population, and patients 65 years or
older, 46.2%. This prevalence of CP in older
adults is in accord with the reported high
prevalence of CP in individuals 65 years or older
[11, 12]. Although age can increase the
probability of developing CP, no causality was
found between age and pain intensity. Thus,
age does not seem to be a predictor of the pain
intensity felt by patients. In fact, the cultural
context might be more important for the per-
ception of pain intensity than age, since if the
individuals believe that a medical consultation
will help, they present to the physician regard-
less of age.
Disability is one of the main consequences of
CP, with a direct impact on patients’ lives and
on the economy [13]. In the studied population,
approximately one in seven (14.4%) CP patients
were on sick leave. Although no direct com-
parisons can be made, Azevedo et al. also
reported that 15% of individuals who suffered
from CP had a severe disability [2], which could
translate into the need for sick leave. Also, in a
European study that did not include Portugal,
Breivik et al. showed that one in four individ-
uals reported that their pain had impacted their
employment status [8], although the percentage
of patients on sick leave was not specified.
Gender is thought to influence the risk of
developing CP, with women being at higher risk
Table 3 Factors that impact general practitioners’ and patients’ expectation of the time needed for pain resolution
Expected time for pain
resolution
Factors that might influence the physicians’
expected time for resolution
Factors that might influence the










\ 1 year 5 (5);
n = 128




1 (2); n = 111
[ 1 year 8 (9); n = 86 9 (3); n = 86 3 (2); n = 86 60 (21);
n = 62
2 (2); n = 62
NIR 6 (6);
n = 364




1 (2); n = 405
Kruskal–Wallis corrected for multiple comparisons using Šidák
\ 1 vs.[ 1 p = 0.001 p = 0.010 p = 0.001 NS p = 0.027
[ 1 vs. NIR NS NS p = 0.017 NS NS
NIR vs.\ 1 p = 0.011 p = 0.044 NS NS NS
A significance level of a = 0.05 was considered
NIR no immediate resolution, NS not significant, PCU primary care unit
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than men [2, 14]. In our cohort, 73.2% of the
individuals were female, which supports the
higher risk of developing CP among women.
Although more than half (60.9%) of the
studied population had more than three
comorbidities, no association between the
existence of comorbidities and pain intensity,
either maximum or average, was observed.
Nevertheless, the presence of comorbidities is
relevant for the treatment of CP, since phar-
macological interactions and effects of the pre-
scribed medication in all pathologies must be
considered [11, 12].
Approximately one third of the studied
population did not feel that their pain was
managed correctly. First-line treatment of
chronic pain usually comprises non-opioid
analgesics such as paracetamol and nons-
teroidal anti-inflammatory drugs [15]. If these
are ineffective, weak and then strong opioids
should be prescribed [15]. However, Portugal is
ranked as one of the countries with the lowest
opioid consumption among western Europe
[7, 16]. Physicians reported legal risk and fear of
adverse events as the main reason for their
reluctance in prescribing opioids [16, 17], which
might explain why 31% of the patients felt that
their treatment was ineffective. Other possible
reasons include lack of support for psychologi-
cal follow-up and for other non-pharmacologi-
cal strategies that could improve CP treatment.
The introduction of psychological support
could help manage CP patients’ expectations
and, consequently, increase treatment adher-
ence. Some patients might feel they would
receive better care in a hospital or might have
misguided expectations regarding the progres-
sion of their condition. Similarly, introduction
of support for non-pharmacological strategies
such as physical rehabilitation could contribute
to improved functionality in these patients and
overall treatment satisfaction.
Additionally, we observed that aspects such
as the number of visits to the PCU, the patients’
notion of how well the physician understood
the severity of their pain, and number of exams
performed influenced the physicians’ expecta-
tion of the time needed to identify an effective
treatment regimen. A higher number of visits to
PCU suggests that the condition is worsening,
Fig. 1 Association between the medical specialty that
diagnosed and/or monitored patients and pain intensity.
The groups studied included patients diagnosed (n = 355)
and monitored (n = 482) by a general practitioner (GP)
and patients diagnosed (n = 100) and monitored (n = 96)
by other medical specialties (other). Columns represent
median values and error bars represent 95% CIs. Between-
group analyses were performed using the Mann–Whitney
test. A significance level of a = 0.05 (two-sided) was used
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explaining the negative impact on the physi-
cians’ expectation. Due to the subjective nature
of pain, good communication between patients
and physicians seems to be essential. The
patient needs to understands that, most likely,
there will not be a cure for their pain, but rather
a good management regimen to ensure the best
possible quality of life. Besides pain relief, CP
treatment aims at decreasing disability and
ameliorating physical and social limitations,
with the ultimate goal of improving patients’
quality of life [7]. Thus, effective communica-
tion will help patients feel that the physician
understands their condition, and will improve
physicians’ ability to identify a good treatment
regimen to which the patients will successfully
adhere. In both these components, no differ-
ence was observed between an expectation of
greater than 1 year and no immediate resolu-
tion (NIR), suggesting that when NIR is pre-
dicted, more than 1 year will be needed to
achieve acceptable pain management. A higher
number of exams negatively impacted physi-
cians’ expectations for pain management. The
need for more exams suggests difficulties in
diagnosing the cause of pain, which would
increase the time needed to identify a good
therapeutic regimen. This difficulty might be
related to the subjectivity of pain, which is
affected by personal bias and by the pain
threshold of each individual. The number of
radiological exams also had a negative impact
on patients’ expectations of pain resolution, as
more exams suggest difficulties in reaching a
diagnosis. Moreover, patients might perceive
that other types of exams, instead of more
radiological exams, would be more useful for
diagnostic purposes.
Patients diagnosed and monitored by medi-
cal specialties other than general practitioners
reported higher levels of pain intensity. This
might be a result of patient referral, as general
practitioners usually refer patients with higher
pain intensity to other medical specialties.
Fig. 2 Association between pain intensity and patients’
mental well-being. Level of maximum pain intensity
described by patients who reported not feeling anxious
and/or depressed (n = 182) and by patients who reported
feeling moderately (n = 313), or extremely (n = 83)
anxious and/or depressed. Columns represent mean values,
and error bars represent 95% CIs. Between-group analyses
were performed using the Kruskal–Wallis test and adjusted
for multiple comparisons using the Šidák correction. A
significance level of a = 0.05 (two-sided) was used
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Moreover, when the patient needs specific
resources, the monitoring of CP patients is
undertaken by these medical specialties.
Although general practitioners might have
more limitations in the exams that they can
prescribe, no significant difference in the time
needed to diagnose CP was observed when
comparing general practitioners with other
medical specialties. In fact, a significant pro-
portion of the population was diagnosed in less
than 6 months, regardless of the specialty of the
physician making the diagnosis.
Depression and anxiety are the most preva-
lent emotional consequences in patients with
CP [2]. In our cohort, patients with higher
intensity of pain were more likely to feel mod-
erately and extremely depressed and/or anx-
ious. This result reflects the huge impact that CP
has on the patients’ quality of life due to pain or
discomfort and due to problems with mobility
and in performing everyday activities. Interest-
ingly, no significant difference was observed
between the levels of pain intensity reported by
individuals who felt moderate and extreme
levels of anxiety/depression, again highlighting
the subjective nature of pain and how the
individual pain threshold may cause differences
in how patients are emotionally affected by CP.
Due to the subjectivity of pain, it is also
important to keep in mind that these results
should be interpreted taking into account the
Portuguese cultural context that will influence
patients’ expectations and knowledge of CP.
Strengths and Limitations
This study analyzed the prevalence of CP in the
PCU. Due to the high prevalence of this con-
dition, a thorough characterization of the pop-
ulation with CP and the impact on their quality
of life is of the utmost importance. Moreover, in
addition to patient interviews, the study inter-
viewed general practitioners, who are usually
the first contact for these patients. On one
hand, to attain a good representation of the
Portuguese population, the geographical distri-
bution of the population was considered in the
selection of the location and number of inclu-
ded PCU. On the other hand, the study was
limited in that it included only mainland Por-
tugal and did not consider the islands of Azores
and Madeira. Another limitation, commonly
observed in CP studies, is related to pain sub-
jectivity. As pain and health-related quality of
life assessment are based on self-reports, there is
always the possibility of bias due to the different
cultural context of patients and their perception
of and tolerance to pain.
CONCLUSIONS
Overall, we determined that CP is highly
prevalent, affecting one third of patients who
present to the PCU. Also, we verified that this
condition has a significant impact on the qual-
ity of life of patients, causing feelings of anxiety
and/or depression. Approximately one in three
CP patients did not feel that their pain was
correctly managed, which underscores the need
for awareness campaigns and information dis-
semination on CP and its treatment. CP treat-
ment should include both pharmacological
treatment for pain relief and non-pharmaco-
logical strategies to increase patients’ functional
ability and well-being, and to decrease feelings
of social isolation, anxiety, and depression.
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